PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26959748-4	2016	Patients with older age, advanced stages, or MYCN amplification showed higher FDG and lower FDOPA SUV(max) (all P < 0.02).	Fluorodeoxyglucose F18	78-81	MYCN proto-oncogene, bHLH transcription factor	Homo sapiens	45-49	
35372427-1	2022	Purpose: This study aimed to assess the predictive ability of 18F-FDG PET/CT radiomic features for MYCN, 1p and 11q abnormalities in NB.	Fluorodeoxyglucose F18	62-69	MYCN proto-oncogene, bHLH transcription factor	Homo sapiens	99-103	
35372427-14	2022	Conclusions: The pre-therapy 18F-FDG PET/CT radiomics is able to predict MYCN amplification and 1p and 11 aberrations in pediatric NB, thus aiding tumor stage, risk stratification and disease management in the clinical practice.	Fluorodeoxyglucose F18	29-36	MYCN proto-oncogene, bHLH transcription factor	Homo sapiens	73-77